Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $77.7 million.

  • Usana Health Sciences' Other Operating Expenses fell 759.39% to $77.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.2 million, marking a year-over-year decrease of 488.07%. This contributed to the annual value of $363.7 million for FY2024, which is 775.08% down from last year.
  • According to the latest figures from Q3 2025, Usana Health Sciences' Other Operating Expenses is $77.7 million, which was down 759.39% from $87.0 million recorded in Q2 2025.
  • Usana Health Sciences' 5-year Other Operating Expenses high stood at $161.2 million for Q1 2022, and its period low was $77.7 million during Q3 2025.
  • In the last 5 years, Usana Health Sciences' Other Operating Expenses had a median value of $97.9 million in 2022 and averaged $106.0 million.
  • In the last 5 years, Usana Health Sciences' Other Operating Expenses surged by 3880.04% in 2021 and then plummeted by 3928.18% in 2022.
  • Quarter analysis of 5 years shows Usana Health Sciences' Other Operating Expenses stood at $116.2 million in 2021, then fell by 15.78% to $97.9 million in 2022, then dropped by 2.04% to $95.9 million in 2023, then dropped by 2.48% to $93.5 million in 2024, then decreased by 16.92% to $77.7 million in 2025.
  • Its Other Operating Expenses was $77.7 million in Q3 2025, compared to $87.0 million in Q2 2025 and $90.0 million in Q1 2025.